Australians with advanced or metastatic gastro-oesophageal cancers will now have cheaper access to drug treatment through the Pharmaceutical Benefits Scheme. The federal government has expanded the PBS listing of nivolumab, which could help up to 1450 patients each year. Without subsidy, a course of the drug could cost more ...
View more: Costs cut for cancer drug